Ocugen Inc [OCGN] stock is trading at $1.67, up 2.45%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OCGN shares have lost -6.70% over the last week, with a monthly amount glided 42.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ocugen Inc [NASDAQ: OCGN] stock has seen the most recent analyst activity on October 15, 2024, when Maxim Group initiated its Buy rating and assigned the stock a price target of $4. Previously, Chardan Capital Markets upgraded its rating to Buy on March 01, 2023, and kept the price target unchanged to $3.50. On August 23, 2022, Mizuho initiated with a Buy rating and assigned a price target of $5 on the stock. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $4.50 as its price target on June 02, 2022. In a note dated June 11, 2021, ROTH Capital downgraded a Neutral rating on this stock and revised its target price from $10 to $6.
Ocugen Inc [OCGN] stock has fluctuated between $0.51 and $1.90 over the past year. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Ocugen Inc [NASDAQ: OCGN] shares were valued at $1.67 at the most recent close of the market. An investor can expect a potential return of 199.4% based on the average OCGN price forecast.
Analyzing the OCGN fundamentals
Ocugen Inc [NASDAQ:OCGN] reported sales of 4.75M for the trailing twelve months, which represents a growth of 20.33%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -11.65%, Pretax Profit Margin comes in at -11.98%, and Net Profit Margin reading is -11.98%. To continue investigating profitability, this company’s Return on Assets is posted at -1.06, Equity is -2.55 and Total Capital is -1.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of10.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Ocugen Inc’s Current Ratio is 1.83. In addition, the Quick Ratio stands at 1.83 and the Cash Ratio stands at 1.5. Considering the valuation of this stock, the price to sales ratio is 109.80, the price to book ratio is 159.81.
Transactions by insiders
Recent insider trading involved MARNA C. WHITTINGTON, Director, that happened on Jul 09 ’25 when 0.11 million shares were purchased. Director, PRABHAVATHI FERNANDES completed a deal on Jun 11 ’25 to buy 0.15 million shares. Meanwhile, Director Fernandes Prabhavathi bought 10000.0 shares on Nov 26 ’24.
